Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of General Psychiatry
Published in: Annals of General Psychiatry 1/2012

Open Access 01-12-2012 | Primary research

Development of the Global Disability Scale (Glo.Di.S): preliminary results

Authors: Konstantinos N Fountoulakis, Eirini Lekka, Evangelia Kouidi, Ioanna Chouvarda, Asterios Deligiannis, Nickolaos Maglaveras

Published in: Annals of General Psychiatry | Issue 1/2012

Login to get access

Abstract

Background

The assessment of functioning and disability is an important part of the clinical evaluation, since it measures disease burden and reflects the effectiveness of therapeutic planning and interventions. The aim of the current study was to develop such a self-report instrument on the basis of a review of the literature, and compatible with the WHO approach.

Material and methods

The review of the literature led to the development of the Global Disability Scale (Glo.Di.S) with 25 items assessing different aspects of disability. The study sample included 728 persons from vulnerable populations (homeless, jobless, very low income, single parent families etc.; (29.12% males and 70.88% females; aged 55.96 ± 15.22 years). The protocol included also the STAI and the CES-D. The statistical analysis included factor analysis item analysis and ANCOVA.

Results

The factor analysis revealed the presence of 4 factors explaining 71% of total variance (Everyday functioning, Social and interpersonal functioning, Severity and Mental disability). Chronbach’s alpha for the whole scale was 0.95 and for subscales were 0.74–0.94.

Discussion

The results of the current study suggest that the Glo.Di.S. has the potential to serve as a reliable and valid tool for assessing functioning and disability. Further research is needed to prove that it could be useful across countries, populations and diseases, and whether it provides data that are culturally meaningful and comparable. It can be used in surveys and in clinical research settings and it can generate information of use in evaluating health needs and the effectiveness of interventions to reduce disability and improve health.
Appendix
Available only for authorised users
Literature
1.
Kostanjsek N, Rubinelli S, Escorpizo R, Cieza A, Kennedy C, Selb M, Stucki G, Ustun TB: Assessing the impact of health conditions using the ICF. Disabil Rehabil. 2010, 33 (15–16): 1475-1482.PubMed
2.
McKibbin C, Patterson TL, Jeste DV: Assessing disability in older patients with schizophrenia: results from the WHODAS-II. J Nerv Ment Dis. 2004, 192 (6): 405-413.CrossRefPubMed
3.
McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC: Childhood adversities and adult psychopathology in the National Comorbidity Survey Replication (NCS-R) III: associations with functional impairment related to DSM-IV disorders. Psychol Med. 2009, 40 (5): 847-859.PubMedCentralCrossRefPubMed
4.
Sheehan DV, Meyers AL, Prakash A, Robinson MJ, Swindle RW, Russell JM, Mallinckrodt CH: The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder. Curr Med Res Opin. 2008, 24 (9): 2457-2466.CrossRefPubMed
5.
Stein DJ, Bandelow B, Dolberg OT, Andersen HF, Baldwin DS: Anxiety symptom severity and functional recovery or relapse. Ann Clin Psychiatry. 2009, 21 (2): 81-88.PubMed
6.
Trivedi MH, Corey-Lisle PK, Guo Z, Lennox RD, Pikalov A, Kim E: Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning. Int Clin Psychopharmacol. 2009, 24 (3): 133-138.CrossRefPubMed
7.
Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A: Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol. 2010, 26 (2): 75-83.CrossRef
8.
Bisdorff A, Andree C, Vaillant M, Sandor PS: Headache-associated dizziness in a headache population: prevalence and impact. Cephalalgia. 2011, 30 (7): 815-820.CrossRef
9.
Roe C, Sveen U, Bautz-Holter E: Retaining the patient perspective in the International Classification of Functioning, Disability and Health Core Set for low back pain. Patient Prefer Adherence. 2008, 2: 337-347.PubMedCentralCrossRefPubMed
10.
Noonan VK, Kopec JA, Noreau L, Singer J, Chan A, Masse LC, Dvorak MF: Comparing the content of participation instruments using the international classification of functioning, disability and health. Health Qual Life Outcomes. 2009, 7: 93-PubMedCentralCrossRefPubMed
11.
World Health Organization: International classification of functioning, disability and health. 2001, WHO, Geneva
12.
World Health Organization: The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 1992, WHO, Geneva
13.
World Health Organization: WHO Psychiatric Disability Assessment Schedule. 1988, WHO, Geneva
14.
Fountoulakis KN, Papadopoulou M, Kleanthous S, Papadopoulou A, Bizeli V, Nimatoudis I, Iacovides A, Kaprinis GS: Reliability and psychometric properties of the Greek translation of the State-Trait Anxiety Inventory form Y: preliminary data. Ann Gen Psychiatry. 2006, 5: 2-PubMedCentralCrossRefPubMed
15.
Fountoulakis K, Iacovides A, Kleanthous S, Samolis S, Kaprinis SG, Sitzoglou K, St Kaprinis G, Bech P: Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry. 2001, 1: 3-PubMedCentralCrossRefPubMed
16.
Buist-Bouwman MA, Ormel J, De Graaf R, Vilagut G, Alonso J, Van Sonderen E, Vollebergh WA: Psychometric properties of the World Health Organization Disability Assessment Schedule used in the European Study of the Epidemiology of Mental Disorders. Int J Methods Psychiatr Res. 2008, 17 (4): 185-197.CrossRefPubMed
17.
Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svetskova O, Burger H, et al: Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes. 2011, 8: 51-CrossRef
18.
Posl M, Cieza A, Stucki G: Psychometric properties of the WHODASII in rehabilitation patients. Qual Life Res. 2007, 16 (9): 1521-1531.CrossRefPubMed
19.
Kutlay S, Kucukdeveci AA, Elhan AH, Oztuna D, Koc N, Tennant A: Validation of the World Health Organization disability assessment schedule II (WHODAS-II) in patients with osteoarthritis. Rheumatol Int. 2009, 31 (3): 339-346.CrossRefPubMed
20.
Schlote A, Richter M, Wunderlich MT, Poppendick U, Moller C, Wallesch CW: Use of the WHODAS II with stroke patients and their relatives: reliability and inter-rater-reliability. Rehabilitation (Stuttg). 2008, 47 (1): 31-38.CrossRef
21.
Schlote A, Richter M, Wunderlich MT, Poppendick U, Moller C, Schwelm K, Wallesch CW: WHODAS II with people after stroke and their relatives. Disabil Rehabil. 2009, 31 (11): 855-864.CrossRefPubMed
22.
Meesters JJ, Verhoef J, Liem IS, Putter H, Vliet Vlieland TP: Validity and responsiveness of the World Health Organization Disability Assessment Schedule II to assess disability in rheumatoid arthritis patients. Rheumatology (Oxford). 2009, 49 (2): 326-333.CrossRef
23.
Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, Couture F, Fitzcharles MA, Gagne M, Garfield B, et al: The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. Arthritis Rheum. 2008, 59 (3): 382-390.CrossRefPubMed
24.
Sousa RM, Dewey ME, Acosta D, Jotheeswaran AT, Castro-Costa E, Ferri CP, Guerra M, Huang Y, Jacob KS, Rodriguez-Pichardo JG, et al: Measuring disability across cultures–the psychometric properties of the WHODAS II in older people from seven low- and middle-income countries, The 10/66 Dementia Research Group population-based survey. Int J Methods Psychiatr Res. 2010, 19 (1): 1-17.PubMedCentralPubMed
25.
Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C: Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010, 88 (11): 815-823.PubMedCentralCrossRefPubMed
26.
Chopra PK, Couper JW, Herrman H: The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II. Aust N Z J Psychiatry. 2004, 38 (9): 753-759.CrossRefPubMed
27.
Andrews G, Kemp A, Sunderland M, von Korff M, Ustun TB: Normative data for the 12 item WHO Disability Assessment Schedule 2.0. PLoS One. 2009, 4 (12): e8343-PubMedCentralCrossRefPubMed
28.
Novak SP, Colpe LJ, Barker PR, Gfroerer JC: Development of a brief mental health impairment scale using a nationally representative sample in the USA. Int J Methods Psychiatr Res. 2010, 19 (Suppl 1): 49-60.CrossRefPubMed
29.
Post MW, de Witte LP, Reichrath E, Verdonschot MM, Wijlhuizen GJ, Perenboom RJ: Development and validation of IMPACT-S, an ICF-based questionnaire to measure activities and participation. J Rehabil Med. 2008, 40 (8): 620-627.CrossRefPubMed
30.
Lam RW, Michalak EE, Yatham LN: A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder. BMC Psychiatry. 2009, 9: 78-PubMedCentralCrossRefPubMed
31.
Leon AC, Olfson M, Portera L, Farber L, Sheehan DV: Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997, 27 (2): 93-105.CrossRefPubMed
32.
Luciano JV, Bertsch J, Salvador-Carulla L, Tomas JM, Fernandez A, Pinto-Meza A, Haro JM, Palao DJ, Serrano-Blanco A: Factor structure, internal consistency and construct validity of the Sheehan Disability Scale in a Spanish primary care sample. J Eval Clin Pract. 2010, 16 (5): 895-901.CrossRefPubMed
33.
Arbuckle R, Frye MA, Brecher M, Paulsson B, Rajagopalan K, Palmer S, Degl’ Innocenti A: The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res. 2009, 165 (1–2): 163-174.CrossRefPubMed
34.
Sheehan DV, Harnett-Sheehan K, Raj BA: The measurement of disability. Int Clin Psychopharmacol. 1996, 11 (Suppl 3): 89-95.CrossRefPubMed
35.
Bobes J, Badia X, Luque A, Garcia M, Gonzalez MP, Dal-Re R: Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia. Med Clin (Barc). 1999, 112 (14): 530-538.
36.
Bez Y, Yesilova Y, Kaya MC, Sir A: High social phobia frequency and related disability in patients with acne vulgaris. Eur J Dermatol. 2011, 21 (5): 756-760.PubMed
37.
Calabrese JR, Hirschfeld RM, Reed M, Davies MA, Frye MA, Keck PE, Lewis L, McElroy SL, McNulty JP, Wagner KD: Impact of bipolar disorder on a U.S. community sample. J Clin Psychiatry. 2003, 64 (4): 425-432.CrossRefPubMed
38.
Chiu JF, Chokka PR: Prevalence of Bipolar Disorder symptoms in Primary Care (ProBiD-PC): A Canadian study. Can Fam Physician. 2011, 57 (2): e58-e67.PubMedCentralPubMed
39.
Gutierrez-Rojas L, Jurado D, Gurpegui M: Factors associated with work, social life and family life disability in bipolar disorder patients. Psychiatry Res. 2011, 186 (2–3): 254-260.CrossRefPubMed
40.
Castrejon I, Silva-Fernandez L, Bombardier C, Carmona L: Clinical composite measures of disease activity for diagnosis and followup of undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl. 2011, 87: 48-53.CrossRefPubMed
41.
Chisolm TH, Abrams HB, McArdle R, Wilson RH, Doyle PJ: The WHO-DAS II: psychometric properties in the measurement of functional health status in adults with acquired hearing loss. Trends Amplif. 2005, 9 (3): 111-126.PubMedCentralCrossRefPubMed
42.
Braga RJ, Mendlowicz MV, Marrocos RP, Figueira IL: Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res. 2005, 39 (4): 409-414.CrossRefPubMed
43.
Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, et al: Disability in people clinically at high risk of psychosis. Br J Psychiatry. 2010, 197 (4): 278-284.CrossRefPubMed
44.
de Portugal E, Gonzalez N, Miriam V, Haro JM, Usall J, Cervilla JA: Gender differences in delusional disorder: Evidence from an outpatient sample. Psychiatry Res. 2011, 177 (1–2): 235-239.
45.
de Portugal E, Martinez C, Gonzalez N, del Amo V, Haro JM, Cervilla JA: Clinical and cognitive correlates of psychiatric comorbidity in delusional disorder outpatients. Aust N Z J Psychiatry. 2011, 45 (5): 416-425.CrossRefPubMed
46.
Dan A, Kumar S, Avasthi A, Grover S: A comparative study on quality of life of patients of schizophrenia with and without depression. Psychiatry Res. 2011, 182 (2): 185-189.CrossRef
47.
Chopra P, Herrman H, Kennedy G: Comparison of disability and quality of life measures in patients with long-term psychotic disorders and patients with multiple sclerosis: an application of the WHO Disability Assessment Schedule II and WHO Quality of Life-BREF. Int J Rehabil Res. 2008, 31 (2): 141-149.CrossRefPubMed
48.
Banerjee A, Kumar S, Kulhara P, Gupta A: Prevalence of depression and its effect on disability in patients with age-related macular degeneration. Indian J Ophthalmol. 2008, 56 (6): 469-474.PubMedCentralCrossRefPubMed
49.
Lin EH, VonKorff M, Russo J, Katon W, Simon GE, Unutzer J, Bush T, Walker E, Ludman E: Can depression treatment in primary care reduce disability? A stepped care approach. Arch Fam Med. 2000, 9 (10): 1052-1058.CrossRefPubMed
50.
Von Korff M, Katon W, Rutter C, Ludman E, Simon G, Lin E, Bush T: Effect on disability outcomes of a depression relapse prevention program. Psychosom Med. 2003, 65 (6): 938-943.CrossRefPubMed
51.
Verger P, Guagliardo V, Gilbert F, Rouillon F, Kovess-Masfety V: Psychiatric disorders in students in six French universities: 12-month prevalence, comorbidity, impairment and help-seeking. Soc Psychiatry Psychiatr Epidemiol. 2009, 45 (2): 189-199.CrossRefPubMed
52.
van der Werff E, Verboom CE, Penninx BW, Nolen WA, Ormel J: Explaining heterogeneity in disability associated with current major depressive disorder: effects of illness characteristics and comorbid mental disorders. J Affect Disord. 2010, 127 (1–3): 203-210.CrossRefPubMed
53.
Scott KM, Collings SC: Gender and the association between mental disorders and disability. J Affect Disord. 2010, 125 (1–3): 207-212.CrossRefPubMed
54.
Olfson M, Broadhead WE, Weissman MM, Leon AC, Farber L, Hoven C, Kathol R: Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry. 1996, 53 (10): 880-886.CrossRefPubMed
55.
Olfson M, Fireman B, Weissman MM, Leon AC, Sheehan DV, Kathol RG, Hoven C, Farber L: Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry. 1997, 154 (12): 1734-1740.CrossRefPubMed
56.
Neal LA, Green G, Turner MA: Post-traumatic stress and disability. Br J Psychiatry. 2004, 184: 247-250.CrossRefPubMed
57.
Langlieb AM, Guico-Pabia CJ: Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder. Prim Care Companion J Clin Psychiatry. 2010, 12 (2): -
58.
Kennedy BL, Lin Y, Schwab JJ: Work, social, and family disabilities of subjects with anxiety and depression. South Med J. 2002, 95 (12): 1424-1427.CrossRefPubMed
59.
Karsten J, Hartman CA, Ormel J, Nolen WA, Penninx BW: Subthreshold depression based on functional impairment better defined by symptom severity than by number of DSM-IV symptoms. J Affect Disord. 2011, 123 (1–3): 230-237.
60.
Gureje O, Ademola A, Olley BO: Depression and disability: comparisons with common physical conditions in the Ibadan study of aging. J Am Geriatr Soc. 2008, 56 (11): 2033-2038.PubMedCentralCrossRefPubMed
61.
Soberg HL, Bautz-Holter E, Roise O, Finset A: Long-term multidimensional functional consequences of severe multiple injuries two years after trauma: a prospective longitudinal cohort study. J Trauma. 2007, 62 (2): 461-470.CrossRefPubMed
62.
Derrett S, Davie G, Ameratunga S, Langley J: Capturing outcomes following injury: a New Zealand pilot study. N Z Med J. 2011, 123 (1316): 66-74.
63.
Derrett S, Langley J, Hokowhitu B, Ameratunga S, Hansen P, Davie G, Wyeth E, Lilley R: Prospective outcomes of injury study. Inj Prev. 2009, 15 (5): e3-CrossRefPubMed
64.
Ferrulli A, Leggio L, Cardone S, D’Angelo C, Mirijello A, Vonghia L, Miceli A, Gasbarrini G, Addolorato G: Psychosocial findings in alcohol-dependent patients before and after three months of total alcohol abstinence. Front Psychiatry. 2011, 1: 17-
65.
Badr HE, Abd El Aziz HM: Role of Gender in Coping Capabilities among Young Visually Disabled Students. J Egypt Public Health Assoc. 2007, 82 (5–6): 365-377.PubMed
66.
Badr HE, Mourad H: Assessment of visual disability using the WHO disability assessment scale (WHO-DAS-II): role of gender. Br J Ophthalmol. 2009, 93 (10): 1365-1370.CrossRefPubMed
67.
Gallagher P, Mulvany F: Levels of ability and functioning: using the WHODAS II in an Irish context. Disabil Rehabil. 2004, 26 (9): 506-517.CrossRefPubMed
68.
Hambrick JP, Turk CL, Heimberg RG, Schneier FR, Liebowitz MR: Psychometric properties of disability measures among patients with social anxiety disorder. J Anxiety Disord. 2004, 18 (6): 825-839.CrossRefPubMed
69.
Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M: Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. J Clin Psychiatry. 2011, 71 (6): 784-792.CrossRef
70.
Khoueiry G, Flory M, Abi Rafeh N, Zgheib MH, Goldman M, Abdallah T, Wettimuny S, Telesford B, Costantino T, McGinn JT: Depression, disability, and quality of life after off-pump coronary artery bypass grafting: a prospective 9-month follow-up study. Heart Lung. 2010, 40 (3): 217-225.CrossRefPubMed
71.
Kim JM, Stewart R, Glozier N, Prince M, Kim SW, Yang SJ, Shin IS, Yoon JS: Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int J Geriatr Psychiatry. 2005, 20 (2): 160-167.CrossRefPubMed
72.
Wang HL, Kroenke K, Wu J, Tu W, Theobald D, Rawl SM: Cancer-Related Pain and Disability: A Longitudinal Study. J Pain Symptom Manage. 2011, 42 (6): 813-821.PubMedCentralCrossRefPubMed
73.
Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS: Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med. 2010, 170 (18): 1686-1694.PubMedCentralCrossRefPubMed
74.
Rodbard HW, Fox KM, Grandy S: Impact of obesity on work productivity and role disability in individuals with and at risk for diabetes mellitus. Am J Health Promot. 2009, 23 (5): 353-360.CrossRefPubMed
75.
Norton J, de Roquefeuil G, Benjamins A, Boulenger JP, Mann A: Psychiatric morbidity, disability and service use amongst primary care attenders in France. Eur Psychiatry. 2004, 19 (3): 164-167.CrossRefPubMed
76.
Scott KM, Von Korff M, Alonso J, Angermeyer MC, Bromet E, Fayyad J, de Girolamo G, Demyttenaere K, Gasquet I, Gureje O, et al: Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med. 2009, 39 (1): 33-43.PubMedCentralCrossRefPubMed
77.
Slim FJ, van Schie CH, Keukenkamp R, Faber WR, Nollet F: Effects of impairments on activities and participation in people affected by leprosy in The Netherlands. J Rehabil Med. 2010, 42 (6): 536-543.CrossRefPubMed
78.
Buitelaar JK, Casas M, Philipsen A, Kooij JJ, Ramos-Quiroga JA, Dejonckheere J, van Oene JC, Schauble B: Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate. Psychol Med. 2011, 42 (1): 195-204.PubMedCentralCrossRefPubMed
79.
Buitelaar JK, Trott GE, Hofecker M, Waechter S, Berwaerts J, Dejonkheere J, Schauble B: Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD. Int J Neuropsychopharmacol. 2011, 29: 1-13.
80.
Whiteside SP: Adapting the Sheehan disability scale to assess child and parent impairment related to childhood anxiety disorders. J Clin Child Adolesc Psychol. 2009, 38 (5): 721-730.CrossRefPubMed
81.
Arun MP, Bharath S, Pal PK, Singh G: Relationship of depression, disability, and quality of life in Parkinson’s disease: a hospital-based case–control study. Neurol India. 2011, 59 (2): 185-189.CrossRefPubMed
82.
Hudson M, Steele R, Taillefer S, Baron M: Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis Rheum. 2008, 59 (2): 270-278.CrossRefPubMed
83.
Hudson M, Thombs BD, Steele R, Watterson R, Taillefer S, Baron M: Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. Arthritis Rheum. 2008, 59 (2): 279-284.CrossRefPubMed
84.
Placchi M: Measuring disability in subjects with anxiety disorders. Eur Psychiatry. 1997, 12 (Suppl 3): 249s-253s.CrossRefPubMed
Metadata
Title
Development of the Global Disability Scale (Glo.Di.S): preliminary results
Authors
Konstantinos N Fountoulakis
Eirini Lekka
Evangelia Kouidi
Ioanna Chouvarda
Asterios Deligiannis
Nickolaos Maglaveras
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2012
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/1744-859X-11-14

Other articles of this Issue 1/2012

Annals of General Psychiatry 1/2012 Go to the issue

Primary research

Sentinel events and predictors of suicide among inpatients at psychiatric hospitals

Primary research

Gender, trauma type, and PTSD prevalence: a re-analysis of 18 nordic convenience samples

Primary research

Deep transcranial magnetic stimulation add-on for the treatment of auditory hallucinations: a double-blind study

Primary research

Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers

Primary research

Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care

Primary research

Body composition in patients with schizophrenia: Comparison with healthy controls